U.S Physical Therapy Long Term Debt 2010-2024 | USPH

U.S Physical Therapy long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
U.S Physical Therapy Annual Long Term Debt
(Millions of US $)
2023 $139
2022 $176
2021 $118
2020 $17
2019 $50
2018 $38
2017 $57
2016 $51
2015 $48
2014 $35
2013 $41
2012 $18
2011 $24
2010 $6
2009 $0
U.S Physical Therapy Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $137
2023-12-31 $139
2023-09-30 $141
2023-06-30 $143
2023-03-31 $183
2022-12-31 $176
2022-09-30 $147
2022-06-30 $149
2022-03-31 $122
2021-12-31 $118
2021-09-30 $35
2021-06-30 $39
2021-03-31 $17
2020-12-31 $17
2020-09-30 $8
2020-06-30 $34
2020-03-31 $119
2019-12-31 $50
2019-09-30 $55
2019-06-30 $66
2019-03-31 $30
2018-12-31 $38
2018-09-30 $55
2018-06-30 $57
2018-03-31 $43
2017-12-31 $57
2017-09-30 $60
2017-06-30 $73
2017-03-31 $63
2016-12-31 $51
2016-09-30 $41
2016-06-30 $47
2016-03-31 $57
2015-12-31 $48
2015-09-30 $48
2015-06-30 $42
2015-03-31 $42
2014-12-31 $35
2014-09-30 $47
2014-06-30 $45
2014-03-31 $46
2013-12-31 $41
2013-09-30 $15
2013-06-30 $16
2013-03-31 $21
2012-12-31 $18
2012-09-30 $16
2012-06-30 $20
2012-03-31 $25
2011-12-31 $24
2011-09-30 $27
2011-06-30 $16
2011-03-31 $5
2010-12-31 $6
2010-09-30 $0
2010-06-30 $4
2010-03-31 $11
2009-12-31 $0
2009-09-30 $4
2009-06-30 $11
2009-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.515B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.097B 10.34
Quest Diagnostics (DGX) United States $15.557B 16.08
DaVita (DVA) United States $11.598B 14.41
Encompass Health (EHC) United States $8.513B 21.79
Chemed (CHE) United States $8.407B 26.06
Elanco Animal Health (ELAN) United States $8.149B 21.14
Option Care Health (OPCH) United States $4.971B 18.82
RadNet (RDNT) United States $4.259B 88.69
Amedisys (AMED) United States $3.144B 22.27
LifeStance Health (LFST) United States $2.217B 0.00
Astrana Health (ASTH) United States $2.112B 28.55
Addus HomeCare (ADUS) United States $1.785B 25.54
Pennant (PNTG) United States $0.681B 35.97
Aveanna Healthcare Holdings (AVAH) United States $0.521B 0.00
Atai Life Sciences (ATAI) Germany $0.273B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00